跳至主要内容
临床试验/CTIS2023-508148-23-01
CTIS2023-508148-23-01进行中(未招募)1 期

Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapy - Etude DAPT-CTO

Assistance Publique Hopitaux De Marseille0 个研究点目标入组 660 人开始时间: 2024年2月7日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
660

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients who underwent a successful coronary stent implantation for chronic coronary occlusion, eligible for long-term aspirin therapy and requiring a dual antiplatelet therapy, Affiliated to Social Security system, Signature of informed consent, Age > 18 years old

排除标准

  • Dual antiplatelet therapy contra-indication, Patient with hypersensitivity to aspirin (or any of its excipients) and/or to any of the active substance or to any of the excipients of the investigational medical product used in this study (clopidogrel), Patient with contraindication to aspirin and/or clopidogrel, No coronary stent implanted, Age<18years, Patient under guardianship, Pregnancy or breast feeding, Prasugrel or ticagrelor use

研究者

相似试验